tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Technical Analysis

2,793 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is 2.31, suggesting Sarepta Therapeutics is a Sell.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 130.01, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 126.75, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.

Sarepta Therapeutics (SRPT) Pivot Points

May 18, 2024, 04:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
128.88
130.49
131.49
133.11
134.11
135.72
136.73
Fibonacci
130.49
131.49
132.11
133.11
134.10
134.72
135.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

May 18, 2024, 04:55 AM
Period
Simple
Exponential
MA5
132.28Buy
132.52Buy
MA10
133.10Sell
131.89Buy
MA20
128.91Buy
130.01Buy
MA50
126.19Buy
126.75Buy
MA100
122.64Buy
122.19Buy
MA200
113.43Buy
117.44Buy
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 131.89, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 122.19, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 126.19, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 122.64, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 113.43, creating a Buy signal.

Sarepta Therapeutics (SRPT) Technical Indicators

May 18, 2024, 04:55 AM
Name
Value
Implied Action
RSI (14)
60.57
Neutral
STOCH (9,6)
18.52
Buy
STOCHRSI (14)
35.71
Neutral
MACD (12,26)
2.31
Sell
ADX (14)
42.37
Neutral
Williams %R
-69.18
Buy
CCI (14)
38.85
Neutral
ATR (14)
4.72
-
Ultimate Oscillator
49.88
Neutral
ROC
3.08
Buy
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 60.57, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 42.37, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is 38.85, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is 3.08, creating a Buy signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Strong Buy.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 60.57, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is 2.31, which suggests SRPT is a Sell.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 132.28, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 128.91, which suggests SRPT is a Buy.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 126.19, which suggests SRPT is a Buy.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 113.43, which suggests SRPT is a Buy.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -69.18, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is 38.85, which suggests SRPT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis